My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries
Merck Kgaa ADR
(OP:
MKKGY
)
25.78
UNCHANGED
Streaming Delayed Price
Updated: 3:58 PM EDT, Oct 16, 2025
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
Price and Volume
Detailed Quote
Volume
0
Open
25.78
Bid (Size)
N/A (0)
Ask (Size)
N/A (0)
Prev. Close
25.78
Today's Range
25.78 - 25.78
52wk Range
24.32 - 36.16
Shares Outstanding
N/A
Dividend Yield
N/A
Intraday
1 Week
1 Month
3 Month
1 Year
3 Year
5 Year
Top News
More News
Avantor Stock Jumps As Activist Investor Urges Sale, Board Shake-Up, And Cost Cuts
August 11, 2025
Engine Capital, holding a 3% stake in Avantor, urges the board to pursue a turnaround or sale, citing years of underperformance, missed targets, and lost market share.
Via
Benzinga
Crown Bioscience San Diego Achieves CLIA Certification to Enhance Clinical Trial Support
July 22, 2025
From
Crown Bioscience
Via
JCN Newswire
Performance
YTD
-10.1%
-10.1%
1 Month
+1.8%
+1.8%
3 Month
-0.5%
-0.5%
6 Month
-3.2%
-3.2%
1 Year
-23.0%
-23.0%
More News
Read More
WeRide, CRISPR And GeneDx Are Among Top 10 Mid-Cap Gainers Last Week (Feb 10-Feb 14): Are The Others In Your Portfolio?
February 16, 2025
Via
Benzinga
Germany's Merck In Talks To Buy Cancer Drug Maker SpringWorks Therapeutics
February 11, 2025
Via
Benzinga
Topics
Intellectual Property
Germany's Merck To Launch Semiconductor Base In China
May 31, 2022
Via
Benzinga
GSK To Buy US-Based Stomach Cancer Drug Developer For Over $1 Billion
January 13, 2025
Via
Benzinga
Pfizer Clears Required Regulatory Hurdles To Complete $43B Seagen Acquisition
December 12, 2023
Via
Benzinga
Merck Germany's Two Pivotal Trials Flunk In Multiple Sclerosis
December 06, 2023
Via
Benzinga
Life Sciences Player Repligen's Strategic European Acquisition - What It Means for Investors
September 26, 2023
Via
Benzinga
Merck Germany Reports 5% Decline In Q2 Sales, Expects More Decline In 2023
August 03, 2023
Via
Benzinga
Novo Nordisk's Obesity Drug Saxenda Not Included In WHO's Essential Drug List
July 26, 2023
Via
Benzinga
Abcam Downgrade: Analyst Trims Expectations Amid Activist Investor Engagement and Potential Bid Anticipation
June 20, 2023
Via
Benzinga
Analyst Says Nektar Therapeutics' Rezpeg Prioritization Likely to Spark Investor Questions
April 18, 2023
Via
Benzinga
FDA Issues Partial Clinical Hold On Merck Germany's Multiple Sclerosis Study
April 12, 2023
Via
Benzinga
Merck Germany Regains Exclusive Global Rights To Cancer Drug From Pfizer
March 27, 2023
Via
Benzinga
Incyte Would Now Compete With Merck, Pfizer As Its Skin Cancer Treatment Scores FDA Accelerated Approval
March 23, 2023
Via
Benzinga
With Upcoming Ovarian Cancer Data, Analyst Sees 100% Upside For Mersana Therapeutics
January 20, 2023
Via
Benzinga
PDS Biotech, Merck Germany Enter Licensing Pact For Investigational Cancer Treatment
January 03, 2023
Via
Benzinga
Mersana Inks Cancer Therapy Development Deal With Merck Germany
December 23, 2022
Via
Benzinga
SpaceX Starlink's New In-Flight Connectivity Service, Amazon's NY Workers Reject Union, Celsius Network Faces Several Federal Investigations: Top Stories Wednesday, Oct. 19
October 19, 2022
Via
Benzinga
Germany's Merck Slapped With Formal French Investigation Related To Its Thyroid Drug
October 19, 2022
Via
Benzinga
PDS Biotech Highlights Expanded Data From PDS0101 Triple Combination Trial In HPV-Positive Cancers
October 11, 2022
Via
Benzinga
TSM Looks To Hire Over 8,000 People In 2022
January 24, 2022
Via
Benzinga
Despite Palantir’s Impressive Deals, Its Losses and Valuation Make It Unappetizing
January 21, 2022
Via
InvestorPlace
The Daily Biotech Pulse: Pfizer Strikes $5.29B COVID Pill Supply Deal With US, Roche's Spark Therapeutics Reports Positive Gene Therapy Readout, EDAP Earnings
November 18, 2021
Via
Benzinga
Frequently Asked Questions
Is Merck Kgaa ADR publicly traded?
Yes, Merck Kgaa ADR is publicly traded.
What exchange does Merck Kgaa ADR trade on?
Merck Kgaa ADR trades on the OTC Traded
What is the ticker symbol for Merck Kgaa ADR?
The ticker symbol for Merck Kgaa ADR is MKKGY on the OTC Traded
What is the current price of Merck Kgaa ADR?
The current price of Merck Kgaa ADR is 25.78
When was Merck Kgaa ADR last traded?
The last trade of Merck Kgaa ADR was at 10/16/25 03:58 PM ET
Stock Quote API & Stock News API supplied by
www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the
Privacy Policy
and
Terms Of Service
.
© 2025 FinancialContent. All rights reserved.